{"id": "1341264807480070145", "creation": 1608617424.0, "user_id": "491043747", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 3, "like_count": 1, "quote_count": 0}}, "text": "#COVAXIN\u2122 clinical trials cross 13,000 subjects, the half way mark and forges ahead, India\u2019s largest Phase III trials\n\n #vaccine\n#COVID19 \n@DDNewsHindi @BharatBiotech https://t.co/F4VqVS0qxp", "first_save": 1634559108.199414, "hashtags": ["#COVAXIN", "#VACCINE", "#COVID19"]}